Sana BiotechnologySANA

那斯達克 · USD
5.00
+0.06
(+1.21%)
收盤 12/12 04:59 (UTC+8)
盤後 
4.93 
4.93 
(-1.40%)
12/12 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
43,51594,97550,63050,86661,76149,372110,72490,6192,181116,289
研發費用
33,23040,02339,14633,58947,70932,93094,45569,835-17,00299,723
推銷及管理費用
10,28510,34111,48417,27714,05216,44216,26920,78419,18316,566
非經常性項目費用
-44,611--------
其他營業費用
----------
營業利益
-43,515
-94,975
-50,630
-50,866
-61,761
-49,372
-110,724
-90,619
-2,181
-116,289
其他收入及費用
1,3631,1751,2411,7971,837-9193,2492,5023,1652,290
利息費用
----------
稅前純益
-42,152
-93,800
-49,389
-49,069
-59,924
-50,291
-107,475
-88,117
984
-113,999
所得稅
----------
稅後純益
-42,152
-93,800
-49,389
-49,069
-59,924
-50,291
-107,475
-88,117
984
-113,999
基本每股稅後盈餘(元)
-0.16-0.39-0.21-0.21-0.25-0.21-0.49-0.450.01-0.59
稀釋每股稅後盈餘(元)
-0.16-0.39-0.21-0.21-0.25-0.21-0.49-0.450.01-0.59
基本平均股數(千股)
260494.00238409.00237578.00236299.00235412.00234440.00217290.00197317.00196978.00192540.00
稀釋平均股數(千股)
260494.00238409.00237578.00236299.00235412.00234440.00217290.00197317.00200473.00192540.00
還原基本每股稅後盈餘(元)
-0.16-0.39-0.21-0.21-0.25-0.21-0.49-0.450.01-0.59
還原稀釋每股稅後盈餘(元)
-0.16-0.39-0.21-0.21-0.25-0.21-0.49-0.450.01-0.59
還原基本平均股數(千股)
260,494238,409237,578236,299235,412234,440217,290197,317196,978192,540
還原稀釋平均股數(千股)
260,494238,409237,578236,299235,412234,440217,290197,317200,473192,540
EBITDA(千元)
-38,961-90,943-45,740-43,376-55,867-46,396-103,729-76,8535,483-109,551

大家都在看

HOT